Abstract: Purpose Excessive blood loss and subsequent blood transfusions in orthopedic procedures have been associated with considerable morbidity and mortality. The primary objective of this study was to determine the incidence of perioperative blood transfusion after hip or knee arthroplasty with the use of tranexamic acid (TXA) versus standard of care. Methods: Any adult patient who underwent a total hip or knee arthroplasty between October 1, 2012 and September 30, 2015 was eligible for inclusion. Patients received 1000 mg of intravenous tranexamic acid preoperatively. Results.........
Keywords: arthroplasty, blood transfusion, thromboembolic complication, tranexamic acid.
[1] Iorio R, Davis CM, III, Healy WL et al, Impact of the economic downturn on adult reconstruction surgery,J Arthroplasty 25, 2010, 1005-1014.
[2] Rana AJ, Iorio R, Healy WL, Hospital economics of primary THA decreasing reimbursement and increasing cost, 1990 to 2008, ClinOrthop469, 2008, 355-361.
[3] Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S et al, Prevention of VTE in orthopedic surgery patients: antithrombic therapy and prevention of thrombosis, 9thed: American College of Chest Physicians evidence-based clinical practice guidelines,Chest 141(suppl), 2012, 278S-325S.
[4] Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C, Reed MR, Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures,Bone Joint J 95, 2013, 1556-1561.
[5] Parvizi J, Mui A, Purtill JJ, Sharkey PF, Hozack WJ, Rothman RH, Total joint arthroplasty: when do fatal or near-fatal compliationsoccur?,J Bone Joint Surg Am 89, 2007, 780-785..